Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 950 participants.

Also called NCT01576016

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 950 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01576016
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Belgium, Finland, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01576016. Non-randomized; no masking; primary purpose treatment. Start 2012-03-30 (actual); primary completion 2018-02-02 (actual). Results posted on 2020-11-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
Condition
Adverse Effect of MRI on an Implanted Pacemaker Lead
Condition
Adverse Effect of MRI on an Implanted Pacemaker
Intervention (Device)
Accent MRI system (lead safety)
Intervention (Device)
Accent MRI system (with MRI scan)
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01576016
Content hash
46828953cc89224875ef5b077dca955d3c4bfd62914ab392e5d468b9ee8196a4